Articles and Insights About Wearables for Clinical Trials

Coalitions

VivoSense Joins CancerX to Advance Digital Innovation in Research

 Ieuan Clay, PhD

On June 2, 2023, at ASCO, CancerX, a public-private partnership co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe), along with the Office for the National Coordinator for Health Information Technology (ONC) and the Office of the Assistant Secretary for Health (OASH), announced its founding members. VivoSense is proud to be among other organizations striving to eradicate cancer!

Read More

VivoSense Joins the FNIH Biomarkers Consortium

 Dudley Tabakin

VivoSense announces that we have joined the Foundation for the National Institutes of Health’s (FNIH) Biomarkers Consortium! This new partnership strengthens our joint mission to facilitate the development of novel digital biomarkers using new and existing technologies, including evidence for their qualification in diagnostic medicine, therapeutic development, and clinical practice improvement.

Read More

VivoSense Joins Clinical Trials Transformation Initiative (CTTI)

 Dudley Tabakin

VivoSense, Inc. has joined the Clinical Trials Transformation Initiative (CTTI) to advance the efficiency and efficacy of clinical trial research and care. As a leading provider of digital endpoint solutions derived from wearable sensors, VivoSense will contribute to CTTI's foundational efforts to improve quality, patient engagement, novel trial design, digital health trials, investigator, and site support and ethics in research.

Read More

VivoSense Announces Expanded Collaboration with RSRT

 Dudley Tabakin

VivoSense announces an expansion of our collaboration with the Rett Syndrome Research Trust (RSRT). Building on the success of our previous collaborations, VivoSense and RSRT will continue to support the development of treatments for Rett Syndrome (RTT) by qualifying objective digital outcome measures of breathing problems for use in RTT trials.

Read More

VivoSense Joins DiMe's Core Measures of Sleep Project

 Kate Lyden, PhD

We are excited to announce our participation in the Digital Medicine Society's (DiMe) latest digital clinical measures project, Core Measures of Sleep. In partnership with the Digital Medicine Society and other leaders in the field, we are paving the way for better approaches to collecting, analyzing, and interpreting sleep data.

Read More

VivoSense Joins DiMe Physical Activity Project

 Kate Lyden, PhD

We are excited to announce our participation in DiMe's Physical Activity, the latest digital clinical measures project. In partnership with the Digital Medicine Society (DiMe) and other leaders in the field, we are developing a core set of digital measures for tracking patients’ physical activity across any therapeutic area.

Clinicians, researchers, and drug developers need to have a shared baseline of digital measures to improve our patients’ health, regardless of their disease or condition. By taking an omni-therapeutic approach, we believe we can reduce time and risk, speeding the development of new therapies to market. Read more about the project.

Read More

VivoSense Joins DTRA to Accelerate Adoption of Decentralized Trials

 Rob Wilson

VivoSense, an agile end-to-end digital clinical endpoint solutions company developing digital endpoints from wearable sensors with their proprietary AI-enabled software platform is proud to join an alliance of over one hundred and twenty life sciences and healthcare organizations that seek to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The Decentralized Trials & Research Alliance (DTRA), is uniting industry stakeholders, including healthcare companies, regulators, patient groups, research organizations and technology providers with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research.

Read More

RSRT Partners with VivoSense to Develop Digital Biomarkers

 Dudley Tabakin


Image Source: RSRT, Randol Family

VivoSense announces a series of new collaborations with the Rett Syndrome Research Trust (RSRT) to develop digital biomarkers that better assess the symptoms of Rett syndrome, focusing on autonomic dysfunction and other difficult-to-evaluate symptoms. The goal in developing these digital biomarkers is to better quantify and understand symptom impact on everyday life and to assess new treatments accurately.

Read More

ActiGraph Partners with VivoSense to Enhance Secure Access to Regulated Sensor Data from Patients in Pharmaceutical Clinical Trials

 Dudley Tabakin

ActiGraph, the leading provider of medical-grade wearable activity and sleep monitoring solutions, has announced a new partnership with data analytics specialist VivoSense. The partnership will enhance the ability of both companies to deliver sponsor access to secure, regulated, analyzed, and contextualized sensor data from patients participating in pharmaceutical clinical trials. VivoSense is a regulatory compliant, cloud based platform for the analysis of wearable sensor data. VivoSense with VivoCapture provides pharmaceutical sponsors with secure access to contextualized sensor data, metadata, analyzed, and raw signals. The platform makes use of Azure authentication and authorization, computing, and storage in a regulated sensor data warehouse.

Read More

Indie Health Partners with VivoSense to Provide Advanced Insights in Chronic Disease Management and Pharmaceutical Clinical Trials

 Dudley Tabakin

San Diego, CA, March 5, 2019 — Biometric sensor provider Indie Health announces its partnership with data analytics specialist VivoSense, to accelerate the delivery of actionable insights and accurate monitoring of patients’ health status. Combining VivoSense software with Indie Health sensor data ensures complete data integrity and structures it within a secure, regulatory-compliant and auditable environment.

Read More
 Newer All Articles Older 

Stay Connected

Popular